Literature DB >> 12142729

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.

Maya K Leabman1, Conrad C Huang, Michiko Kawamoto, Susan J Johns, Douglas Stryke, Thomas E Ferrin, Joseph DeYoung, Travis Taylor, Andrew G Clark, Ira Herskowitz, Kathleen M Giacomini.   

Abstract

The completion of the Human Genome Project and the development of high-throughput polymorphism identification methods have allowed researchers to carry out full genetic analyses of many clinically relevant genes. However, few studies have combined genetic analysis with in vitro phenotyping to better understand the relationship between genetic variation and protein function. Many transporters in the kidney are thought to play key roles in defense against a variety of foreign substances. The goal of this study was to understand the relationship between variation in a gene encoding a major renal xenobiotic transporter, OCT2, and transporter function. We report a comprehensive genetic analysis and functional characterization of variants of OCT2. Twenty-eight variable sites in the OCT2 gene were identified in a collection of 247 ethnically diverse DNA samples. Eight caused non-synonymous amino acid changes, of which four were present at >/= 1% in an ethnic population. All four of these altered transporter function assayed in Xenopus laevis oocytes. Analysis of nucleotide diversity (pi) revealed a higher prevalence of synonymous (pi = 22.4 x 10-4) versus non-synonymous (pi = 2.1 x 10-4) changes in OCT2 than in other genes. In addition, the non-synonymous sites had a significant tendency to exhibit more skewed allele frequencies (more negative Tajima's D-values) compared to synonymous sites. The population-genetic analysis, together with the functional characterization, suggests that selection has acted against amino acid changes in OCT2. This selection may be due to a necessary role of OCT2 in the renal elimination of endogenous amines or xenobiotics, including environmental toxins, neurotoxic amines and therapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142729     DOI: 10.1097/00008571-200207000-00007

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  43 in total

Review 1.  The pharmacogenetics of metformin.

Authors:  Jose C Florez
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.

Authors:  Morne Du Plessis; Brendon Pearce; Clifford Jacobs; Nisreen Hoosain; Mongi Benjeddou
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

3.  Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3).

Authors:  Andreas Lazar; Dirk Gründemann; Reinhard Berkels; Dirk Taubert; Tim Zimmermann; Edgar Schömig
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

4.  Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor.

Authors:  Dana D Phan; Peter Chin-Hong; Emil T Lin; Pascale Anderle; Wolfgang Sadee; B Joseph Guglielmo
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

5.  Functional genomics of membrane transporters in human populations.

Authors:  Thomas J Urban; Ronnie Sebro; Evan H Hurowitz; Maya K Leabman; Ilaria Badagnani; Leah L Lagpacan; Neil Risch; Kathleen M Giacomini
Journal:  Genome Res       Date:  2005-12-14       Impact factor: 9.043

Review 6.  The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs.

Authors:  N van Leeuwen; J J Swen; H-J Guchelaar; L M 't Hart
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

7.  Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.

Authors:  Ying Chen; Kristen Teranishi; Shuanglian Li; Sook Wah Yee; Stephanie Hesselson; Doug Stryke; Susan J Johns; Thomas E Ferrin; Pui Kwok; Kathleen M Giacomini
Journal:  Pharmacogenomics J       Date:  2009-01-27       Impact factor: 3.550

8.  Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.

Authors:  Faisal E Al Jofi; Tao Ma; Dong Guo; Monica P Schneider; Yan Shu; Hockin H K Xu; Abraham Schneider
Journal:  Cytotherapy       Date:  2018-03-16       Impact factor: 5.414

Review 9.  Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.

Authors:  Thomas Gerloff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-04       Impact factor: 3.000

10.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Authors:  Yan Shu; Steven A Sheardown; Chaline Brown; Ryan P Owen; Shuzhong Zhang; Richard A Castro; Alexandra G Ianculescu; Lin Yue; Joan C Lo; Esteban G Burchard; Claire M Brett; Kathleen M Giacomini
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.